Estrogen Receptor Positive/Progesterone Receptor Negative Breast Carcinomas: A Subgroup Deserves Particular Interest

View/ Open
Date
2015-08-01Author
Gucin, ZÜHALSONMEZ, Cavide
Ersoy, YELİZ EMİNE
MUSLUMANOGLU, Mahmut
GECER, Melin Ozgun
Buyukpinarbasili, NUR
Advisor
Type
Metadata
Show full item recordAbstract
Objective: Breast carcinomas positive for the estrogen receptor (ER+) but negative for the progesterone receptor (PR-) have unfavorable prognostic features and are resistant to tamoxifen therapy. The goal of this study was to highlight the significance of PR-breast carcinomas.
Subject
Collections
- Bezmialem Science Koleksiyonu [59]
- Tıp Fakültesi [2546]
- WoS İndeksli Yayınlar Koleksiyonu [5147]